BC
AUPH icon

Brookfield Corp’s Aurinia Pharmaceuticals AUPH Stock Holding History

Brookfield Corp’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-150,633
Closed -$1.46M – 147
2023
Q2 		$1.46M Buy
+150,633
New +$1.56M 0.01% 437
2022
Q2 		– Hold
0
– – – 598
2022
Q1 		– Sell
-240,000
Closed -$3.71M – 622
2021
Q4 		$5.49M Buy
240,000
+191,482
+395% +$4.54M 0.02% 203
2021
Q3 		$1.07M Buy
48,518
+1,211
+3% +$19.2K ﹤0.01% 411
2021
Q2 		$613K Buy
+47,307
New +$603K ﹤0.01% 498

Other funds holding AUPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return